Rontalizumab (RhuMab IFNalpha) is a humanized monoclonal antibody that neutralizes IFNalpha, used in the study of systemic lupus erythematosus and other neurological disorders.
Purity:
97.73%
CAS Number:
[948570-30-7]
Target:
COX
* VAT and and shipping costs not included. Errors and price changes excepted